| Dr Aida Avdic, MD | |
|
17 Belmont Ave Ste 1, Brattleboro, VT 05301-3498 | |
| (802) 257-0341 | |
| (802) 257-8834 |
| Full Name | Dr Aida Avdic |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 17 Belmont Ave Ste 1, Brattleboro, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154484772 | NPI | - | NPPES |
| 3101856 | Medicaid | NH | |
| 1020214 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 042.0012317 (Vermont) | Primary |
| 207R00000X | Internal Medicine | FA1452969 (Vermont) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brattleboro Memorial Hospital | Brattleboro, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brattleboro Memorial Hospital | 9335112929 | 74 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.
Today's healthcare facilities seek to manage patient radiation dose while maintaining high image quality for accurate diagnoses. Dr. Jeff Dardinger from St. Elizabeth Healthcare in Edgewood, Ky., will discuss the initial findings of using Toshiba's AIDR 3D with the AquilionTM ONE CT system to lower dose while maintaining high image quality across multiple CT exams.
A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.
Brain damage can cause significant changes in behaviour, such as loss of cognitive skills, but also reveals much about how the nervous system deals with consciousness. New findings reported in the July 2011 issue of Elsevier's Cortex demonstrate how the unconscious brain continues to process information even when the conscious brain is incapacitated.
Aperion Biologics, Inc. was granted the CE Mark approval for its lead product, the Z-Lig ACLR device, to be used by surgeons in the European Union and other territories that accept the CE Mark.
› Verified 3 days ago
| Entity Name | Brattleboro Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306849708 PECOS PAC ID: 9335112929 Enrollment ID: O20040929000782 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.
Today's healthcare facilities seek to manage patient radiation dose while maintaining high image quality for accurate diagnoses. Dr. Jeff Dardinger from St. Elizabeth Healthcare in Edgewood, Ky., will discuss the initial findings of using Toshiba's AIDR 3D with the AquilionTM ONE CT system to lower dose while maintaining high image quality across multiple CT exams.
A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.
Brain damage can cause significant changes in behaviour, such as loss of cognitive skills, but also reveals much about how the nervous system deals with consciousness. New findings reported in the July 2011 issue of Elsevier's Cortex demonstrate how the unconscious brain continues to process information even when the conscious brain is incapacitated.
Aperion Biologics, Inc. was granted the CE Mark approval for its lead product, the Z-Lig ACLR device, to be used by surgeons in the European Union and other territories that accept the CE Mark.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aida Avdic, MD 3400 Spruce St, Penn Tower Suit 2009, Philadelphia, PA 19104-4206 Ph: (215) 662-3797 | Dr Aida Avdic, MD 17 Belmont Ave Ste 1, Brattleboro, VT 05301-3498 Ph: (802) 257-0341 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.
Today's healthcare facilities seek to manage patient radiation dose while maintaining high image quality for accurate diagnoses. Dr. Jeff Dardinger from St. Elizabeth Healthcare in Edgewood, Ky., will discuss the initial findings of using Toshiba's AIDR 3D with the AquilionTM ONE CT system to lower dose while maintaining high image quality across multiple CT exams.
A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.
Brain damage can cause significant changes in behaviour, such as loss of cognitive skills, but also reveals much about how the nervous system deals with consciousness. New findings reported in the July 2011 issue of Elsevier's Cortex demonstrate how the unconscious brain continues to process information even when the conscious brain is incapacitated.
Aperion Biologics, Inc. was granted the CE Mark approval for its lead product, the Z-Lig ACLR device, to be used by surgeons in the European Union and other territories that accept the CE Mark.
› Verified 3 days ago
Eric R Pofcher, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Belmont Ave, Brattleboro, VT 05301 Phone: 802-258-3905 Fax: 802-258-4903 | |
Laura S Metsch, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Belmont Ave, Brattleboro, VT 05301 Phone: 802-258-3905 Fax: 802-258-4903 | |
Carolyn Louise Taylor-olson, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 17 Belmont Ave, Brattleboro, VT 05301 Phone: 802-442-8164 | |
Antoine E Soueid, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17 Belmont Ave Ste 1, Brattleboro, VT 05301 Phone: 802-257-0341 Fax: 802-257-8834 | |
Dr. Burton David Tepfer, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 19 Belmont Ave, Suite 202, Brattleboro, VT 05301 Phone: 802-257-0505 Fax: 802-257-4665 | |
Dr. Jeffry Brian Potash, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 63 Belmont Ave, Suite 2, Brattleboro, VT 05301 Phone: 802-254-4947 Fax: 802-257-1454 |